Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

23.67
Delayed Data
As of Jun 24
 -0.17 / -0.71%
Today’s Change
20.07
Today|||52-Week Range
42.48
-16.33%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close23.84
Today’s open22.76
Day’s range22.45 - 23.88
Volume533,845
Average volume (3 months)314,868
Market cap$757.6M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.86%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio98.9
Price/Sales11.37
Price/Book6.05

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.43-7.08%
FOLDAmicus Therapeutics ...-0.46-7.78%
FWPForward Pharma A/S-1.17-6.30%
MACKMerrimack Pharmaceut...-0.41-6.70%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs